US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Biomarkers Market Research Reports & Industry Analysis

The high specificity required of biomarkers in research, drug development and clinical diagnostics creates significant diversity in the global biomarkers market. The greatest focus in biomarkers development is oncology with cancer biomarkers occupying the largest space at over 25% of the market. Biomarkers are parameters or analytes integral to or associated with a biochemical, anatomical, pathogenic, pharmacologic or molecular (genetic) process of clinical interest.

Biomarker discovery continues to power the development of in vitro diagnostic (IVD) tests used to diagnose disease and health conditions, predict patient response to therapy, and monitor therapeutic effects and patient health. Ideal biomarkers have excellent sensitivity and specificity in terms of identifying disease, determining disease state, or evaluating patient response to therapy. Biomarkers are generally proteins (products of gene expression) or nucleic acid sequences (either RNA or DNA); small molecules that are products of metabolism may also serve as biomarkers.

The proliferation of biomarkers is a result of greater clinical understanding of the interconnections between genetics, proteomics and gene expression, disease susceptibility, disease manifestation, and disease susceptibility to select therapies. Biomarkers can be classified as natural history markers (allow for the detection and isolation of a particular cell type), drug activity markers (indicate patient response to pharmological intervention), or surrogate markers (markers that can be used as an alternative to traditional endpoints such as morbidity and mortality to evaluate the effectiveness of a therapy in treating disease). Genomic research is expected to further expand the availability of biomarkers for various diseases and make significant contributions to personalized medicine.

In addition to cancer biomarkers, biomarkers are also available for cardiac function and episodes, other cardiovascular conditions, coagulation or hemostasis, endocrine function, blood sugar management, autoimmune disorders, inflammation, specific infectious diseases, sepsis, and neurological disorders. Over half of the biomarkers market exists in clinical applications, the rest in drug development, research and clinical trial applications. Biomarkers are broadly used for disease risk assessment, diagnosis, screening, treatment or therapy selection, and therapeutic monitoring.

RSS Feeds

Biomarkers Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  
Global Cancer Biomarkers Industry 2015 Market Research Report
8/13/2015 | published by: QYResearch Group
... definitions, classifications, applications and industry chain structure.The Cancer Biomarkers market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as ...  |  read more...
USD 2,800
Global Biomarkers Industry 2015 Market Research Report
8/18/2015 | published by: QYResearch Group
... report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Dilated Cardiomyopathy Therapeutics market analysis is provided for the international markets including development trends, competitive landscape analysis, and key ...  |  read more...
USD 2,800
Global JAK and PI3K Signaling Pathway Industry 2015 Market Research Report
8/18/2015 | published by: QYResearch Group
... basic overview of the industry including definitions, classifications, applications and industry chain structure.The JAK and PI3K Signaling Pathway market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions ...  |  read more...
USD 2,800
Global Cardiac Markers Market 2015-2019
8/26/2015 | published by: TechNavio - Infiniti Research Ltd.
... expensive, and simple technique that helps a physician to decide whether the patient needs an invasive or complicated procedure. The cardiac marker testing is widely used in many medical settings especially for patients at low ...  |  read more...
USD 2,500
2015-2019 World Tumor Marker and Special Chemistry Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan - Competitive Strategies, Supplier Shares, Country Segment Forecasts, Innovative Technologies, Instrumentation Review
7/27/2015 | published by: VPGMarketResearch.com
... profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: AFP CA 15-3/27-29 CA 19-9 CEA Follate (Folic Acid) Glycosylated Hemoglobin HCG 25-Hydroxy Vitamin ...  |  read more...
USD 8,500
2015-2019 World Tumor Marker Diagnostic Market: Strategic Assessments of Major Suppliers and Emerging Market Entrants
6/26/2015 | published by: VPGMarketResearch.com
... of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains 80 pages Please note: The delivery time for the electronic version of this report ...  |  read more...
USD 2,500
2015-2019 Global CA Tumor Markers Diagnostics Market: US, Europe, Japan - Emerging Opportunities and Business Strategies - Competitive Landscape, Supplier Shares, Country Volume and Sales Segment Forecasts
7/7/2015 | published by: VPGMarketResearch.com
... the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting ...  |  read more...
USD 5,450
2015-2019 Global CA Tumor Markers Testing Market: Emerging Opportunities, Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Landscape - US, Europe (France, Germany, Italy, Spain, UK), Japan
6/22/2015 | published by: VPGMarketResearch.com
... the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting ...  |  read more...
USD 5,450
2015-2019 German Tumor Marker Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies
6/26/2015 | published by: VPGMarketResearch.com
... markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies ...  |  read more...
USD 6,800
2015-2019 Italian Tumor Marker Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies
6/26/2015 | published by: VPGMarketResearch.com
... markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies ...  |  read more...
USD 6,800
2015-2019 UK Tumor Marker Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies
6/26/2015 | published by: VPGMarketResearch.com
... markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies ...  |  read more...
USD 6,800
2015-2019 Japanese Tumor Marker Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies
6/26/2015 | published by: VPGMarketResearch.com
... markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies ...  |  read more...
USD 7,600
2015-2019 US Hospital Tumor Marker Testing Market Forecasts and Emerging Opportunities for Suppliers - Competitive Landscape, Supplier Shares by Test, Innovative Technologies, Instrumentation Review
7/16/2015 | published by: VPGMarketResearch.com
... key economic, regulatory, demographic, social and technological trends with significant market impact during the next 5 years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, ...  |  read more...
USD 6,500
Biomarkers Market by Product (Consumables, Services), Type (Predictive, Pharmacodynamic, Safety), Application (Diagnostics, Drug Discovery, Personalized Medicine) & by Disease Indication (Cardiovascular, Immunological) - Global Forecast to 2020
7/17/2015 | published by: MarketsandMarkets
... segmented on the basis of product, type, application, disease indication, and geography. The product segments included in this report are consumables, services, software. The type segments included in this report are safety biomarkers, efficacy biomarkers, ...  |  read more...
USD 4,650
Global Cancer Diagnostics(Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) Industry Report 2015
7/15/2015 | published by: QYResearch Group
... The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Cancer Diagnostics(Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) market analysis is provided for the international markets including development ...  |  read more...
USD 2,800
Future Horizons and Growth Strategies in the German Tumor Marker Testing Market 2015: Supplier Shares and Country Forecasts
6/16/2015 | published by: VPGMarketResearch.com
... during the next ten years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. ...  |  read more...
USD 6,800
Future Horizons and Growth Strategies in the Spanish Tumor Marker Testing Market 2015: Supplier Shares and Country Forecasts
6/16/2015 | published by: VPGMarketResearch.com
... during the next five years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. ...  |  read more...
USD 6,800
Future Horizons and Growth Strategies in the German Hospital Tumor Marker Testing Market 2015: Supplier Shares and Country Forecasts
6/16/2015 | published by: VPGMarketResearch.com
... key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, ...  |  read more...
USD 3,850
Future Horizons and Growth Strategies in the Japanese Hospital Tumor Marker Testing Market 2015: Supplier Shares and Country Forecasts
6/16/2015 | published by: VPGMarketResearch.com
... key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, ...  |  read more...
USD 4,850
MicroRNAs in Cancer Drug Pipeline Update 2015
6/17/2015 | published by: BioSeeker Group AB
... with minimal toxicities either as a monotherapy or perhaps even more likely in a combinatorial drug setting. miRNA may also hold great potential as biomarkers, albeit a lot of work is a head of us ...  |  read more...
USD 6,750
2015-2019 Global Tumor Markers Testing Market: US, Europe, Japan - Strategic Profiles of Leading Suppliers, Country Volume and Sales Forecasts
7/14/2015 | published by: VPGMarketResearch.com
... of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains 104 pages and 3 tables Please note: The ...  |  read more...
USD 3,500
2015-2019 World Tumor Marker Testing Market Overview: Test Volume and Sales Forecasts by Country
6/26/2015 | published by: VPGMarketResearch.com
... well as ten-year test volume and sales forecasts by country. Contains 11 pages and 3 tables Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow ...  |  read more...
USD 2,450
2015-2019 World Tumor Marker Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies - France, Germany, Italy, Japan, Spain, UK, US
6/26/2015 | published by: VPGMarketResearch.com
... The report examines trends in the U.S., Europe and Asia; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading ...  |  read more...
USD 34,750
2015-2019 French Tumor Marker Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies
6/26/2015 | published by: VPGMarketResearch.com
... markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies ...  |  read more...
USD 6,800
2015-2019 Spanish Tumor Marker Testing Market: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies
6/26/2015 | published by: VPGMarketResearch.com
... markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies ...  |  read more...
USD 6,800
< prev 1    3  4  5  6  7  8